Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01892371
Title Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center

chronic myeloid leukemia

myelodysplastic syndrome

acute myeloid leukemia


Azacitidine + Quizartinib

Cytarabine + Quizartinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST